Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Haegarda
Marketing
New HAE drugs from Takeda, BioCryst are gaining popularity
Orladeyo’s growth will mainly come at the expense of CSL’s Berinert and Haegarda, while Takeda’s Takhzyro will also gain share, one analyst says.
Angus Liu
Mar 18, 2022 11:16am
ICER is urging steep discounts on Takeda and CSL drugs
Aug 24, 2021 2:18pm
Can durability data keep Takeda's Takhzyro in control in HAE?
Jul 12, 2021 12:59pm
CSL sues former exec for trade secrets theft
Oct 17, 2019 11:13am
Want to thrive, pharma? Forget 'me-too' drugs, CSL chief says
Jan 14, 2019 11:18am
Shire eyes blockbuster sales with new HAE drug Takhzyro
Aug 24, 2018 11:11am
